Yi-Ting Wang is a highly skilled scientist specializing in target proteomics, currently employed at Kymera Therapeutics since July 2023 as a Target Proteomics Scientist. Previous experience includes roles as a Biomedical Scientist and Postdoctoral Fellow at Pacific Northwest National Laboratory from October 2017 to March 2023, and as a Postdoctoral Fellow at Kyoto University from September 2015 to October 2017, where expertise in mass spectrometry and proteomics was developed. Yi-Ting Wang also served as a Postdoctoral Research Fellow at Academia Sinica in Taiwan from August 2014 to July 2015, focusing on clinical proteomics and post-translational modifications. Educational credentials include a Doctor of Philosophy in Biochemistry from National Taiwan University, completed in 2014.